These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 9451471)

  • 1. Increased CD5+CD19+ B lymphocytes at the onset of type 1 diabetes in children.
    De Filippo G; Pozzi N; Cosentini E; Cavalcanti M; Carel JC; Tamasi S; Franzese A; Pignata C
    Acta Diabetol; 1997 Dec; 34(4):271-4. PubMed ID: 9451471
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-islet cell and anti-insulin antibody production by CD5+ and CD5- B lymphocytes in IDDM.
    Muñoz A; Gallart T; Usac EF; Fernández-Alvarez J; Viñas O; Somoza N; Barceló J; Gomis R
    Diabetologia; 1995 Jan; 38(1):62-72. PubMed ID: 7538087
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD5+ B-cells at the onset of type I diabetes and in the prediabetic period.
    Smerdon RA; Peakman M; Hussain MJ; Wong FS; Watkins PJ; Leslie RD; Vergani D
    Diabetes Care; 1994 Jul; 17(7):657-64. PubMed ID: 7523048
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fetal type lymphocytes in insulin dependent diabetes mellitus.
    Gyarmati J; Szekeres-Barthó J; Fischer B; Soltész G
    Autoimmunity; 1999; 30(2):63-9. PubMed ID: 10435718
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiparametric immunophenotyping of B cells in peripheral blood of healthy adults by flow cytometry.
    Höffkes HG; Schmidtke G; Uppenkamp M; Schmücker U
    Clin Diagn Lab Immunol; 1996 Jan; 3(1):30-6. PubMed ID: 8770500
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of CD5 on B lymphocytes correlates with disease activity in patients with multiple sclerosis.
    Seidi OA; Semra YK; Sharief MK
    J Neuroimmunol; 2002 Dec; 133(1-2):205-10. PubMed ID: 12446024
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD5+ B lymphocytes in high-risk islet cell antibody-positive and newly diagnosed IDDM subjects.
    Schatz DA; Lang F; Cantor AB; Riley WJ; Maclaren NK; Sleasman JW; Barrett DJ
    Diabetes; 1991 Oct; 40(10):1314-8. PubMed ID: 1718800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IL-10 is predominantly produced by CD19(low)CD5(+) regulatory B cell subpopulation: characterisation of CD19 (high) and CD19(low) subpopulations of CD5(+) B cells.
    Lee JH; Noh J; Noh G; Choi WS; Lee SS
    Yonsei Med J; 2011 Sep; 52(5):851-5. PubMed ID: 21786452
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in lymphocyte subsets in children with newly diagnosed type 1 diabetes mellitus.
    Kadziela K; Kowalska H; Rymkiewicz-Kluczyńska B; Kowalska M; Miszkurka G; Rybczyńska J; Wasik M; Pańkowska E
    J Pediatr Endocrinol Metab; 2003 Feb; 16(2):185-91. PubMed ID: 12713255
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased CD5+ B-cells are associated with autoimmune phenomena in lepromatous leprosy patients.
    Kotb A; Ismail S; Kimito I; Mohamed W; Salman A; Mohammed AA
    J Infect Public Health; 2019; 12(5):656-659. PubMed ID: 30904499
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Imbalance of B-Lymphocyte Subsets in Subjects with Different Glucose Tolerance: Relationship with Metabolic Parameter and Disease Status.
    Deng C; Xiang Y; Tan T; Ren Z; Cao C; Liu B; Huang G; Wang X; Zhou Z
    J Diabetes Res; 2017; 2017():5052812. PubMed ID: 28491871
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced percentage of CD5+ B lymphocytes in newly diagnosed IDDM patients.
    Nicoletti F; Meroni PL; Barcellini W; Steinsväg PO; Di Mauro M; Lunetta M; Pagano M; Consoli U; Zanussi C
    Immunol Lett; 1990 Jan; 23(3):211-5. PubMed ID: 1689697
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CSF B-cell expansion in opsoclonus-myoclonus syndrome: a biomarker of disease activity.
    Pranzatelli MR; Travelstead AL; Tate ED; Allison TJ; Verhulst SJ
    Mov Disord; 2004 Jul; 19(7):770-777. PubMed ID: 15254934
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased CD5-positive B lymphocytes in type I diabetes.
    Muñoz A; Gallart T; Viñas O; Gomis R
    Clin Exp Immunol; 1991 Feb; 83(2):304-8. PubMed ID: 1704297
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decreases in CD5+ B lymphocytes in children with the DiGeorge anomaly.
    Kourtis AP; Ibegbu CC; Lee FK; Vogler L; Philips K; Nahmias AJ
    Scand J Immunol; 1997 Sep; 46(3):281-3. PubMed ID: 9315117
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD19+CD5+ B cells in primary IgA nephropathy.
    Yuling H; Ruijing X; Xiang J; Yanping J; Lang C; Li L; Dingping Y; Xinti T; Jingyi L; Zhiqing T; Yongyi B; Bing X; Xinxing W; Youxin J; Fox DA; Lundy SK; Guohua D; Jinquan T
    J Am Soc Nephrol; 2008 Nov; 19(11):2130-9. PubMed ID: 18650480
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Shift in the B cell subsets between children with type 1 diabetes and/or celiac disease.
    Tompa A; Faresjö M
    Clin Exp Immunol; 2024 Mar; 216(1):36-44. PubMed ID: 38134245
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phenotypic characteristics of B cells in Behçet's disease: increased activity in B cell subsets.
    Ekşioglu-Demiralp E; Kibaroglu A; Direskeneli H; Yavuz S; Karsli F; Yurdakul S; Yazici H; Akoglu T
    J Rheumatol; 1999 Apr; 26(4):826-32. PubMed ID: 10229403
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD43 and CD5 antibodies define four normal and neoplastic B-cell subsets: a three-color flow cytometric study.
    Lynch EF; Jones PA; Swerdlow SH
    Cytometry; 1995 Sep; 22(3):223-31. PubMed ID: 8556954
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD5+ B cells and naturally occurring autoantibodies in cancer patients.
    Stein R; Witz IP; Ovadia J; Goldenberg DM; Yron I
    Clin Exp Immunol; 1991 Sep; 85(3):418-23. PubMed ID: 1716541
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.